Ever Source Wealth Advisors, LLC Vaxcyte, Inc. Transaction History
Ever Source Wealth Advisors, LLC
- $1.65 Billion
- Q4 2024
A detailed history of Ever Source Wealth Advisors, LLC transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 51 shares of PCVX stock, worth $3,630. This represents 0.0% of its overall portfolio holdings.
Number of Shares
51
Previous 25
104.0%
Holding current value
$3,630
Previous $2,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding PCVX
# of Institutions
350Shares Held
130MCall Options Held
539KPut Options Held
253K-
Vanguard Group Inc Valley Forge, PA12MShares$851 Million0.02% of portfolio
-
Janus Henderson Group PLC London, X010.6MShares$753 Million0.46% of portfolio
-
Black Rock Inc. New York, NY9.94MShares$708 Million0.02% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.69MShares$618 Million11.52% of portfolio
-
Capital Research Global Investors Los Angeles, CA6.21MShares$442 Million0.11% of portfolio
About Vaxcyte, Inc.
- Ticker PCVX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,315,100
- Market Cap $4.22B
- Description
- Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...